DUBLIN, July 28, 2025 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2025 financial results and provide a business update after market close on Tuesday, August 12, 2025. An accompanying conference call and simultaneous webcast will be hosted at…
